Switch to: References

Add citations

You must login to add citations.
  1. Global Health Governance: Commission on Social Determinants of Health and the Imperative for Change.Ruth Bell, Sebastian Taylor & Michael Marmot - 2010 - Journal of Law, Medicine and Ethics 38 (3):470-485.
    In May 2009 the World Health Assembly passed a resolution on reducing health inequities through action on the social determinants of health, based on the work of the global Commission on Social Determinants of Health, 2005–2008. The Commission's genesis and findings raise some important questions for global health governance. We draw out some of the essential elements, themes, and mechanisms that shaped the Commission. We start by examining the evolving nature of global health and the Commission's foundational inspiration – the (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Global Health Governance: Commission on Social Determinants of Health and the Imperative for Change.Ruth Bell, Sebastian Taylor & Michael Marmot - 2010 - Journal of Law, Medicine and Ethics 38 (3):470-485.
    On August 28, 2008, Michael Marmot, Chair of the Commission on Social Determinants of Health, formally handed over the Commission’s Final Report to Margaret Chan, the Director-General of the World Health Organization, at the Palais des Nations in Geneva. It was a significant moment. Dr. Chan addressed a hall packed with representatives of the world’s communications media in a speech that was remarkably direct. Dr. Chan reiterated the Commission’s position that to improve health and health equity action needs to be (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.
    Instead of impeding access to essential medicines in developing countries, the essay explores why and how patents can serve as a source of funding for the much needed access to medicine. Instead of a weakening of patents, prolonged protection periods are suggested in circumstances where there is widespread lack of access. The revenues from extended patents are seen as a source of funding for drug donations to the least developed countries.
    Download  
     
    Export citation  
     
    Bookmark